News Novartis/Amgen migraine drug shows promise Mid-stage data suggests drug reduces monthly migraine days.
News Teva collaborates with Intel to develop Huntington's smartwa... Teva enters the machine learning market.
News GW could be next big pharma takeover target UK firm has hired bankers to deal with approaches - press reports.
Articles How industry should improve beyond-the-pill-programmes Patient support programmes that extend beyond the prescription are increasingly important, with neurologists among the most experienced in such services.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.